LEADS BioLabs
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
An antibody-focused biotech generating novel biologics for cancer and immune disorders.
OncologyImmunology
Technology Platform
Operates an integrated antibody discovery and engineering platform for generating monoclonal and engineered antibodies against novel targets.
Opportunities
Potential to discover a blockbuster antibody against a novel pathway in oncology or autoimmunity.
Risk Factors
Risk of target or molecule failure in clinical trials, alongside significant commercial competition from established antibodies.
Competitive Landscape
Enters a highly competitive antibody therapeutics market, requiring highly differentiated biology or superior molecule engineering to succeed.